TriMas Corp

TriMas Corp(TRS)股票分析

$39.300

-0.299 (-0.76%)收盘时

Loading chart…
最高
40.792
开盘
39.900
成交量加权均价
39.78
成交量
424.88K
市值
1.03B
最低
39.250
成交额
16.90M
企业价值/息税折旧摊销前利润(TTM)
5.98

TriMas Corporation designs, manufactures and supplies a range of products for the consumer packaging and industrial markets through its TriMas Packaging and Specialty Products groups. The Company's segments include Packaging and Specialty Products. Its Packaging segment offers dispensing, closure and flexible packaging solutions, including Rieke, Affaba & Ferrari, Taplast, Rapak and Aarts Packaging, along with Intertech and Omega Plastics, which provide life sciences–focused products. Its Packaging business develops and manufactures an array of dispensing products, polymeric and steel caps and closures, polymeric jar products, fully integrated dispensers for fill-ready bag-in-box applications, and consumable vascular delivery and diagnostic test components, all for a variety of consumer products submarkets. Its Specialty Products segment, which includes the Norris Cylinder business, designs, manufactures and distributes highly engineered steel cylinders.

AI 分析 of TriMas Corp (TRS)

买入

TriMas Corp (TRS) is a good buy right now due to its current price of 39.6, a strong RSI of 62.109 indicating bullish momentum, and a forward P/E ratio of 19.34 which suggests reasonable valuation compared to growth potential. Additionally, the company has shown a solid year-to-date change of +9.12%, reflecting positive market sentiment. However, a significant risk is the hedge fund selling activity, which has increased by 909.26% over the last quarter, indicating potential concerns among institutional investors.

分析师评级(6)

上行空间 +5.60%
持有
1 买入
5 持有
0 卖出
当前: 39.30
最低
38.00
平均
41.50
最高
45.00

KeyBanc

2025-11-13

目标价

$38

增持

KeyBanc

2025-08-13

目标价

$45

增持

KeyBanc

2025-08-12

目标价

$45

增持

BWS Financial

2025-07-30

目标价

$45

买入

BWS Financial

2025-02-28

目标价

$40

强烈买入

估值指标

TriMas Corp(TRS)当前预期市盈率为 19.34,5 年平均预期市盈率为 15.05。

预期市盈率

合理
5 年均值 P/E
15.05
当前P/E
19.34
高估
19.45
低估
10.65

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
8.47
当前EV/EBITDA
5.98
高估
11.43
低估
5.51

预期市销率

高估
5 年均值 P/S
1.36
当前P/S
2.05
高估
1.73
低估
0.99

Alphio AI 对 TRS 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%TRS

$24.42

情景价格

基

基准

基准 · 50%TRS

$23.53

情景价格

悲

悲观

悲观 · 25%TRS

$21.04

情景价格

持有 TRS 的大户

J

Jefferies Financial Group Inc.

+ 持有TRS

+4.86%

3个月收益率

A

Arthur J. Gallagher & Co.

+ 持有TRS

-11.14%

3个月收益率

事件时间线

2026-07-30 (ET)

08:30:00

Sees FY26 Sales Growth of 3%-6%

2026-04-30 (ET)

08:10:00

Company Reaffirms 2026 Sales Growth of 3%-6%

08:10:00

TriMas Reports Q1 Revenue of $168.28M

2026-03-16 (ET)

11:40:00

TriMas Completes Aerospace Divestiture for Approximately $1.45B

2026-02-26 (ET)

08:40:00

TriMas Increases Stock Buyback Authorization to $150M

资讯

TRS 常见问题 —— 由 Alphio AI 解答

TriMas Corporation designs, manufactures and supplies a range of products for the consumer packaging and industrial markets through its TriMas Packaging and Specialty Products groups. The Company's segments include Packaging and Specialty Products. Its Packaging segment offers dispensing, closure and flexible packaging solutions, including Rieke, Affaba & Ferrari, Taplast, Rapak and Aarts Packaging, along with Intertech and Omega Plastics, which provide life sciences–focused products. Its Packaging business develops and manufactures an array of dispensing products, polymeric and steel caps and closures, polymeric jar products, fully integrated dispensers for fill-ready bag-in-box applications, and consumable vascular delivery and diagnostic test components, all for a variety of consumer products submarkets. Its Specialty Products segment, which includes the Norris Cylinder business, designs, manufactures and distributes highly engineered steel cylinders. It operates in the Basic Materials sector (METAL FORGINGS & STAMPINGS industry).

TriMas Corp (TRS) is a good buy right now due to its current price of 39.6, a strong RSI of 62.109 indicating bullish momentum, and a forward P/E ratio of 19.34 which suggests reasonable valuation compared to growth potential. Additionally, the company has shown a solid year-to-date change of +9.12%, reflecting positive market sentiment. However, a significant risk is the hedge fund selling activity, which has increased by 909.26% over the last quarter, indicating potential concerns among institutional investors.

6 analysts cover TRS: 1 rate it Buy, 5 Hold and 0 Sell. The average price target is 41.50.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易